Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data
Tumori Journal · 2023-06 · 109 (3) · 282-294
DOI: 10.1177/03008916221109334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tumori Journal, online erschienen am 27.07.2022. Verfasst von Yang-Yu Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou…. Hauptthemen laut MEDLINE: Thymoma, Thymus Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: the Wu Jie-ping Medical Foundation.
Abstract (Originalsprache)
Background
Thymic carcinoma (TC) is a rare malignant tumor that can have a poor prognosis, and accurate prognostication prediction remains difficult. We aimed to develop a nomogram to predict overall survival (OS) and cancer-specific survival (CSS) based on a large cohort of patients.
Methods
The Surveillance Epidemiology and End Results (SEER) database was searched to identify TC patients (1975–2016). Univariate and multivariable Cox regression analyses were used to identify predictors of OS and CSS, which were used to construct nomograms. The nomograms were evaluated using the concordance index (C-index), calibration curve, receiver operating characteristic curve, and decision curve analysis (DCA). Subgroup analysis was performed to identify high-risk patients.
Results
The analysis identified six predictors of OS (Masaoka stage, surgical method, lymph node metastasis, liver metastasis, bone metastasis, and radiotherapy) and five predictors of CSS (Masaoka stage, surgical method, lymph node metastasis, tumor size, and brain metastasis), which were used to create nomograms for predicting three-year and five-year OS and CSS. The nomograms had reasonable C-index values (OS: 0.687 [training] and 0.674 [validation], CSS: 0.712 [training] and 0.739 [validation]). The DCA curve revealed that the nomograms were better for predicting OS and CSS, relative to the Masaoka staging system.
Conclusion
We developed nomograms using eight clinicopathological factors that predicted OS and CSS among TC patients. The nomograms performed better than the traditional Masaoka staging system and could identify high-risk patients. Based on the nomograms’ performance, we believe they will be useful prognostication tools for TC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Yang-Yu Huang, Lei-Lei Wu
Förderung
- the Wu Jie-ping Medical Foundation
Zitieren
APA
Huang, Y. Y., Liu, X., Liang, S. H., Wu, L. L., & Ma, G. W. (2023). Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data. Tumori Journal, 109(3), 282-294. https://doi.org/10.1177/03008916221109334
Vancouver
Huang YY, Liu X, Liang SH, Wu LL, Ma GW. Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data. Tumori Journal. 2023;109(3):282-294. doi:10.1177/03008916221109334
BibTeX
@article{Huang2023,
author = {Huang, Yang-Yu and Liu, Xuan and Liang, Shen-Hua and Wu, Lei-Lei and Ma, Guo-Wei},
title = {Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data},
journal = {Tumori Journal},
year = {2023},
volume = {109},
number = {3},
pages = {282--294},
doi = {10.1177/03008916221109334}
}
EUVIMED